| scholarly article | Q13442814 |
| P2093 | author name string | Ellis J | |
| MacGregor EA | |||
| Aspinall L | |||
| Hackshaw A | |||
| Frith A | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | placebo | Q269829 |
| menstruation | Q12171 | ||
| migraine | Q133823 | ||
| P304 | page(s) | 2159-2163 | |
| P577 | publication date | 2006-12-01 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. | |
| P478 | volume | 67 |
| Q46354531 | Alternatives to beta blockers in preventive migraine treatment |
| Q37798757 | Are the current IHS guidelines for migraine drug trials being followed? |
| Q37363483 | Clinical aspects of perimenstrual headaches |
| Q37973415 | Combined hormonal contraceptives: is it time to reassess their role in migraine? |
| Q45995793 | Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials. |
| Q33687184 | Contraceptive-induced amenorrhoea leads to reduced migraine frequency in women with menstrual migraine without aura |
| Q37216396 | Current and prospective pharmacological targets in relation to antimigraine action |
| Q46791913 | Current diagnosis and treatment of migraine |
| Q35610954 | Does pain vary across the menstrual cycle? A review. |
| Q56976562 | Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH) |
| Q89110504 | Estrogen, migraine, and vascular risk |
| Q37242949 | Estrogen-growth factor interactions and their contributions to neurological disorders |
| Q24633546 | Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society |
| Q37154795 | Frovatriptan for the acute treatment of migraine and prevention of predictable menstrual migraine |
| Q46191351 | Headache and hormone replacement therapy in the postmenopausal woman |
| Q37788968 | Hormonal contraceptive options for women with headache: a review of the evidence |
| Q37591553 | Hormonal therapies for menstrual migraine |
| Q46812006 | Hormone withdrawal-associated symptoms: comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate |
| Q39020464 | Hormone-Related Migraine Headaches and Mood Disorders: Treatment with Estrogen Stabilization |
| Q93373090 | Male and female sex hormones in primary headaches |
| Q34338801 | Management of menstrual migraine: a review of current abortive and prophylactic therapies |
| Q39026779 | Menstrual Migraine and Treatment Options: Review |
| Q85056313 | Menstrual and nonmenstrual migraines differ in women with menstrually-related migraine |
| Q50047547 | Menstrual migraine: a review of current and developing pharmacotherapies for women |
| Q36904875 | Menstrual migraine: a review of hormonal causes, prophylaxis and treatment |
| Q38237616 | Menstrual migraine: an updated review on hormonal causes, prophylaxis and treatment |
| Q36941893 | Menstrual migraine: clinical and therapeutical aspects |
| Q34409246 | Menstrual migraine: therapeutic approaches |
| Q34655746 | Migraine and hormones: what can we be certain of? |
| Q36146747 | Migraine and possible etiologic heterogeneity for hormone-receptor-negative breast cancer |
| Q84979042 | Migraine and reproductive life |
| Q38215468 | Migraine and the menopausal transition |
| Q36594614 | Migraine during perimenopause |
| Q37591558 | Migraine headache in perimenopausal and menopausal women |
| Q38504731 | Migraine in perimenopausal women |
| Q37991005 | Neuroendocrine aspects of migraine in women |
| Q37306327 | Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study |
| Q37052803 | Optimizing prophylactic treatment of migraine: Subtypes and patient matching |
| Q37363486 | Perimenstrual headache: treatment options |
| Q37313514 | Perimenstrual headaches: unmet needs |
| Q42669098 | Perimenstrual migraines and their response to preventive therapy with topiramate |
| Q34623397 | Prevention and Treatment of Menstrual Migraine |
| Q36873484 | Preventive treatment in migraine and the new US guidelines |
| Q35697308 | Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition, 2012 |
| Q38218704 | Sex disparities in neuro-ophthalmologic disorders |
| Q43265529 | Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks |
| Q35742998 | Systematic Review of Preventive and Acute Treatment of Menstrual Migraine |
| Q58781288 | TRP Channels as Potential Targets for Sex-Related Differences in Migraine Pain |
| Q90294264 | The Relationship between the Phases of the Menstrual Cycle on the Incidence and Severity of Headache after Spinal Anesthesia |
| Q38854096 | The impact of pregnancy on headache evaluation in the emergency department, a retrospective cohort study. |
| Q38038990 | Transdermal hormonal therapy in perimenstrual migraine: why, when and how? |
| Q51314345 | Treatment strategies for menstrually related migraine. |
| Q36749560 | Triptans in prevention of menstrual migraine: a systematic review with meta-analysis |
| Q80769364 | [Headache and migraine] |
Search more.